LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Clinical trials for LEFT VENTRICULAR SYSTOLIC DYSFUNCTION explained in plain language.
Never miss a new study
Get alerted when new LEFT VENTRICULAR SYSTOLIC DYSFUNCTION trials appear
Sign up with your email to follow new studies for LEFT VENTRICULAR SYSTOLIC DYSFUNCTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for kids with weak hearts: long-term safety study launched
Disease control Recruiting nowThis study tests the long-term safety of finerenone, a medicine that may help the heart pump better by reducing inflammation and scarring. It is for children from birth to 18 years old with heart failure and a weak left ventricle. All participants will take finerenone along with …
Matched conditions: LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New hope for kids with heart failure: drug trial aims to improve heart function
Disease control Recruiting nowThis study tests whether the drug vericiguat can help children with heart failure caused by a weak left heart chamber. About 342 children aged 1 month to 18 years will receive either vericiguat or a placebo for 16 weeks. The main goal is to see if the drug lowers a key heart stre…
Matched conditions: LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Phase: PHASE2, PHASE3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 14:01 UTC
-
New drug trial aims to help kids with heart failure
Disease control Recruiting nowThis phase 3 study tests whether finerenone, a drug that blocks inflammation and scarring in the heart, can improve heart function in children aged 6 months to 18 years with heart failure and left ventricular systolic dysfunction. About 111 participants will receive either finere…
Matched conditions: LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Phase: PHASE3 • Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a daily iron pill boost energy in heart failure?
Disease control Recruiting nowThis study tests whether a daily oral iron supplement (sucrosomial iron with vitamin C) can improve exercise ability and quality of life in people with chronic heart failure and iron deficiency. About 60 participants will receive either the iron supplement or a placebo for 24 wee…
Matched conditions: LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Phase: PHASE4 • Sponsor: Raffaele De Caterina • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Heart scans may predict Post-Surgery risks in valve patients
Knowledge-focused Recruiting nowThis pilot study at Mayo Clinic will use cardiac MRI scans to examine how the heart's main pumping chamber changes in people with severe mitral regurgitation before and after valve repair surgery. The goal is to see if this approach can help identify patients at risk of developin…
Matched conditions: LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:10 UTC
-
Skin scans may reveal hidden heart risks in older adults
Knowledge-focused Recruiting nowThis study looks at whether simple, non-invasive skin tests can detect early signs of heart disease by measuring how well small blood vessels work. Researchers will study 900 people aged 60-75, comparing skin blood flow measurements with detailed heart scans. The goal is to find …
Matched conditions: LEFT VENTRICULAR SYSTOLIC DYSFUNCTION
Sponsor: HJN Sverige AB/Neko Health • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC